CID 118752983

Sipoglitazar metabolite m-i

Structural Information

Molecular Formula
C23H21N3O4S
SMILES
C1=CC=C(C=C1)C2=NC(=CS2)COC3=CC=C(C=C3)CN4C=C(C(=O)N4)CCC(=O)O
InChI
InChI=1S/C23H21N3O4S/c27-21(28)11-8-18-13-26(25-22(18)29)12-16-6-9-20(10-7-16)30-14-19-15-31-23(24-19)17-4-2-1-3-5-17/h1-7,9-10,13,15H,8,11-12,14H2,(H,25,29)(H,27,28)
InChIKey
FLJUMKJOWRMKTG-UHFFFAOYSA-N
Compound name
3-[5-oxo-2-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]-1H-pyrazol-4-yl]propanoic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

435.12527 Da
Monoisotopic Mass

3.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 436.132546 201.1
[M+Na]+ 458.114488 209.9
[M-H]- 434.117994 209.5
[M+NH4]+ 453.159093 209.2
[M+K]+ 474.088428 202.7
[M+H-H2O]+ 418.122530 191.9
[M+HCOO]- 480.123471 216.7
[M+CH3COO]- 494.139121 210.1
[M+Na-2H]- 456.099936 197.7
[M]+ 435.12472142 206.7
[M]- 435.12581858 206.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.